Drugs / JUVIA
last change Jan 2025 re-read 2 minutes ago

JUVIA

Developed for
vulvovaginal candidiasis
Investigated by
FEMPHARMA Kft.

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05895162 Jun 2023 → Dec 2024 vulvovaginal candidiasis FEMPHARMA Kft. Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as JUVIA ClinicalTrials.gov intervention name — accepted as the source's own label NCT05895162